AcroMeta (SGX:43F) has entered into a side letter extending the exclusivity period for the proposed sale of its 70% stake in its unit Life Science Incubator, according to a Monday filing on the Singapore Exchange.
The new exclusivity period runs until Sept. 30.
The side letter updates certain terms and conditions of the previous non-binding term sheet signed on May 11. Key commercial terms remain unchanged.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.